Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AMRESCO FLOW PAC CARBON DIOXIDE (CO2) REAGENTS

K-Number: K860660 · 1986-03-14

ApplicantAmresco, Inc.
Decision Date1986-03-14
Product CodeCHS
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

AMRESCO FLOW PAC CARBON DIOXIDE (CO2) REAGENTS is the device name listed in this FDA 510(k) record. The listed applicant is Amresco, Inc.. It received FDA 510(k) clearance on 1986-03-14 under 510(k) number K860660. The device is classified under product code CHS. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AMRESCO FLOW PAC CARBON DIOXIDE (CO2) REAGENTS?

AMRESCO FLOW PAC CARBON DIOXIDE (CO2) REAGENTS is a medical device that received FDA 510(k) clearance on 1986-03-14. The listed applicant is Amresco, Inc.. The 510(k) number is K860660.

When did AMRESCO FLOW PAC CARBON DIOXIDE (CO2) REAGENTS receive FDA 510(k) clearance?

AMRESCO FLOW PAC CARBON DIOXIDE (CO2) REAGENTS received FDA 510(k) clearance on 1986-03-14, under 510(k) number K860660.

Who is the listed applicant for AMRESCO FLOW PAC CARBON DIOXIDE (CO2) REAGENTS?

The FDA 510(k) record lists Amresco, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AMRESCO FLOW PAC CARBON DIOXIDE (CO2) REAGENTS?

The FDA product code for AMRESCO FLOW PAC CARBON DIOXIDE (CO2) REAGENTS is CHS.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Amresco, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K905618GGT REAGENTK904468DIRECT BILIRUBIN REAGENT, 7776/7777/7576/7476/7176K905684ALKALINE PHOSPHATASEK905544MAGNESIUM REAGENTK905284HDL-CHOLESTEROL PRECIPITANT 7773/7573/7473/7173K904004AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116

View all 39 devices →

Related Devices (Code: CHS)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K926320REFLAB SYSTEM PACK LIQUID CO2 REAGENTMedical Analysis Systems, Inc.K911838ROCHE REAGENT FOR C02Roche Diagnostic Systems, Inc.K841080TECHNICON RA-1000 SYS CO2Technicon Instruments Corp.K811257CORNING 965 CARBON DIOXIDE ANALYZERCorning Medical & ScientificK802376KODAK EKTA-CHEM CLINICAL CHEM. SLIDESEastman Kodak Company

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑